Applicatory study of natural compounds with receptor blocking effect to vasodilator

具有受体阻断作用的天然化合物在血管扩张剂中的应用研究

基本信息

  • 批准号:
    10557228
  • 负责人:
  • 金额:
    $ 8.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

Hypertension triggers various vascular diseases such as arteriosclerosis, angina or myocardial infarction. Since in general, it is necessary to administer vasodilator chronically to patients in hypertension, it is socially important to develop good medicine with less side effects. Human beings have been utilize vegetoanimal products as medicine for thousands of years. Furthermore, there are huge amount of synthesized medicines which are originated from natural products. Our aim of this study is to seak lead compound from natural resources such as traditional medicinal plants or marine organisms, synthesize derivatives and develop good vasodilator with small side effects. We have discovered physiologically active isolated from natural resources which act on α-adrenergic receptor, serotonergic receptor or muscle contractile proteins. In isolated rat fundus, guinea pig trachea or rabbit aorta, nantenine, isolated from methanol extract of nanten fruit, moved concentration-contraction curve of serotonin toward right in parallel manner. Nantenine also moved concentration-contraction curve of phenylephrine toward right. Therefore, it is suggested that nantenine possessing both α-adrenergic- and serotonergic-blocking effects. We have also successfully isolated new types of anti-serotonergic and anti-histaminergic contents from Thai medicinal plant Garcinia mangostana, traditionally used as anti-inflammatory. γ-Mangostin, content showing anti-serotonergic effect, showed not only inhibited contraction in aorta, but also showed anti-serotonergic effect in central nerve system. We also studied the central effect of compound which affect on CaィイD12+ィエD1 release sarcoplasmic reticulum, the key of excitation-contraction coupling in muscle.
高血压会引发各种血管疾病,如动脉硬化、心绞痛或心肌梗死。一般来说,高血压患者长期服用血管扩张剂是必要的,因此开发副作用较少的好药具有重要的社会意义。几千年来,人类一直使用动植物产品作为药物。此外,还有大量来自天然产物的合成药物。本研究的目的是从传统的药用植物或海洋生物等自然资源中提取先导化合物,合成衍生物,开发副作用小的良好的血管扩张剂。我们已经发现从自然资源中分离出来的作用于α-肾上腺素能受体、5-羟色胺能受体或肌肉收缩蛋白的生理活性物质。在大鼠眼底、豚鼠气管和兔主动脉上,从南藤果甲醇提取物中分离得到的南藤碱使5-羟色胺的浓度-收缩曲线平行右移。南替宁还使去氧肾上腺素的浓度-收缩曲线右移。因此,我们认为南藤碱同时具有α-肾上腺素能和5-羟色胺能阻断作用。我们还成功地从泰国药用植物山竹中分离出了新型的抗5-羟色胺能和抗组胺能成分,传统上用于抗炎。γ-芒果苷具有抗5-羟色胺作用,不仅对主动脉收缩有抑制作用,对中枢神经系统也有抗5-羟色胺作用。我们还研究了影响钙ィイD12+ィエD1释放肌浆网的中枢作用,肌浆网是肌肉兴奋-收缩偶联的关键。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chairungsrilerd,N.et al.: "γ-Mangostin,a novel type of 5-hydroxytryptamine_<2A>receptor antagonists." Naunyn-Schmiedeberg Arch.Pharmacol.357. 25-31 (1998)
Chairungsrilerd,N.等:“γ-Mangostin,一种新型5-羟色胺_ 2A 受体拮抗剂。”Naunyn-Schmiedeberg Arch.Pharmacol.357 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tadano T.et al.: "Central action of 9-methyl-7-bromoeudistomin D (MBED), a derivative of eudistomin D isolated from Eudistoma olivaceum"Methods and Findings in Experimental and Clinical Pharmacology. 20. 53-58 (1999)
Tadano T.等人:“9-甲基-7-bromoeudistomin D (MBED) 的中心作用,是从 Eudistoma olivaceum 中分离出的 eudistomin D 衍生物”实验和临床药理学的方法和发现。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chairungsrilerd,N.et al.: "Effect of γ-mangostin through the inhibition of 5-hydroxytriptamine_<2A>receptors in 5-fluoro-α-methyltryptamine-induced head-twitch responses of mice." Br.J.Pharmacol.123. 855-862 (1998)
Chairungsrilerd,N.等人:“γ-山竹素通过抑制 5-羟基三胺_<2A>受体对 5-氟-α-甲基色胺诱导的小鼠头部抽搐反应的影响。” Br.J.Pharmacol.123 .855-862 (1998)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seino-Umeda.A.et al.: "9-Methyl-7-bromoeudistomine D induces remarkablely Ca^<2+> release from cardiac sarcoplasmic reticulum." Eur.J.Pharmacol.357. 261-265 (1998)
Seino-Umeda.A.等人:“9-甲基-7-溴乌司托明 D 显着诱导心脏肌浆网释放 Ca^2”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHIZUMI Yasushi其他文献

OHIZUMI Yasushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHIZUMI Yasushi', 18)}}的其他基金

Pharmacological study of intarcellular signal transduction using marine natural products as pharmacological tools.
使用海洋天然产物作为药理学工具进行细胞内信号转导的药理学研究。
  • 批准号:
    12470492
  • 财政年份:
    2000
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pharmacological studies on bioactive compounds isolated from marine organisms
从海洋生物中分离的生物活性化合物的药理学研究
  • 批准号:
    10470479
  • 财政年份:
    1998
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of the mechanism of excitatory action of marine natural products on platelets and muscle cells
阐明海洋天然产物对血小板和肌肉细胞的兴奋作用机制
  • 批准号:
    08457603
  • 财政年份:
    1996
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic and applied studies on cardiotonic
强心剂的基础与应用研究
  • 批准号:
    05557103
  • 财政年份:
    1993
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Pharmacological studies on toxins from marine organism
海洋生物毒素的药理研究
  • 批准号:
    05454567
  • 财政年份:
    1993
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了